FIELD: chemistry.
SUBSTANCE: invention discloses lysobactin derivatives, synthesis method thereof, as well as use thereof to prepare medicinal agents for treating and/or preventing diseases caused by bacteria. The lysobactin derivatives are distinguished from natural substance by presence of an N-terminal peptide chain which contains a 3-(3-pyridyl)alanyl residue.
EFFECT: compositions are highly effective.
10 cl, 1 tbl, 10 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SUBSTITUTED DIHYDROPYRAZOLONES FOR TREATING CARDIOVASCULAR AND HEMATOLOGIC DISEASES, USE THEREOF, DRUG AND METHOD OF TREATING AND/OR PREVENTING | 2012 |
|
RU2611012C2 |
| NEW CYCLOPENTA[B]BENZOFURANYL DERIVATIVES AND APPLICATION THEREOF | 2005 |
|
RU2415847C9 |
| PIPERIDINYLPYRAZOLOPYRIMIDINONES AND USE THEREOF | 2015 |
|
RU2713937C2 |
| ERBB RECEPTOR INHIBITORS | 2019 |
|
RU2810215C2 |
| BENZOXAZEPINE PI3 INHIBITORS AND METHODS OF USE | 2010 |
|
RU2654068C1 |
| HETEROCYCLYLAMIDE-SUBSTITUTED THAIZOLES, PYRROLES AND THIOPHENES | 2006 |
|
RU2425829C2 |
| REPLACED DIHYDROPYRAZOLONES AS INHIBITORS OF HIF-PROLYL-4-HYDROXYLASE | 2009 |
|
RU2509080C9 |
| PIPERIDINE UREA DERIVATIVES | 2014 |
|
RU2666894C2 |
| SUBSTITUTED OXOPYRIDINE DERIVATIVE | 2019 |
|
RU2792645C2 |
| ERBB/BTK INHIBITORS | 2019 |
|
RU2764069C1 |
